Pseudomonas Aeruginosa (Serotype 9) antibody

Antigen: Pseudomonas Aeruginosa (Serotype 9)

Clonality: Polyclonal

Host: Chicken

Reactivity: Pseudomonas aeruginosa (P. aeruginosa)

Application: Western Blotting (WB)

Catalog no.: ABIN249414

Additional Information

Alternative name: Pseudomonas aeruginosa

Immunogen: whole, formaldehyde killed, bacteria, strains PAO1 and Habs1

Format: Liquid

Description: Pseudomonas aeruginosa is Gram-negative, aerobic, rod-shaped bacteria withunipolar motility. An opportunistic human pathogen, P. aeruginosa is also anopportunistic pathogen of plants. P. aeruginosa bacterias are clinically importantbecause they are resistant to most antibiotics and they are capable of surviving inconditions that few other organisms can tolerate. Pseudomonas is oftenencountered in hospital and clinical work because it is a major cause of hospitalacquired (nosocomal) infections. Its main targets are immunocompromisedindividuals, burn victims, and individuals on respirators or with precipitationprocedure followed by indwelling catheters. Additionally, these pathogenscolonize the lungs of cystic fibrosis patients. P. aeruginosa is often identified by itspearlescent appearance and grape-like odor in vitro. Definitive clinicalidentification of P. aeruginosa includes identifying the

Specificity: Pseudomonas aeruginosa strains PAO1 , Habs1

Application Details

Application Notes: Recommended Dilution 1: 1000 - 1: 5 000 with standard ECL (WB), 1: 1000 - 1: 5 000 (ELISA). Additional Information: the IgY fraction is isolated by a two-step PEG precipitation procedure followed byammonium sulphate precipitation .

Buffer: Total IgY fraction at 13.2 mg/ml in 0.9% NaCl, 0.1% sodiumazide

Storage: store at 4°C, make aliquots to avoid working with a stock. Please, remember tospin tubes briefly prior to opening them to avoid any losses that might occur fromliquid material adhering to the cap or sides of the tubes.

Research Area: Bacteria

Restrictions: For Research Use only